(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.19%) $80.21
(1.45%) $2.66
(0.72%) $2 434.80
(3.87%) $32.47
(0.95%) $1 100.40
(-0.02%) $0.920
(-0.11%) $10.66
(0.02%) $0.787
(0.09%) $91.05
Quarter results today
(bmo 2024-05-20)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore...
Stats | |
---|---|
Today's Volume | 160 058 |
Average Volume | 421 242 |
Market Cap | 82.75M |
EPS | NZD0 ( 2023-11-21 ) |
Next earnings date | ( NZD0 ) 2024-05-20 |
Last Dividend | NZD0 ( N/A ) |
Next Dividend | NZD0 ( N/A ) |
P/E | -3.40 |
ATR14 | NZD0.00100 (0.98%) |
Pacific Edge Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pacific Edge Limited Financials
Annual | 2023 |
Revenue: | NZD19.62M |
Gross Profit: | NZD9.60M (48.96 %) |
EPS: | NZD-0.0333 |
FY | 2023 |
Revenue: | NZD19.62M |
Gross Profit: | NZD9.60M (48.96 %) |
EPS: | NZD-0.0333 |
FY | 2022 |
Revenue: | NZD11.45M |
Gross Profit: | NZD4.56M (39.85 %) |
EPS: | NZD-0.0258 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Pacific Edge Limited
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, the company is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators